View from the Board: Managing Teams During a Pandemic

More than half of biotech CEOs are first-time CEOs, but even the most experienced leadership teams faced unprecedented management challenges with the advent of COVID-19. As the COVID-19 outbreak continues to wreak havoc across the globe, boards of directors have a critical oversight role to play in helping their companies navigate through these uncertain times. Strained supply chains, liquidity concerns, financial strains, absent employees, a move to remote working: the list of operating challenges seems endless. This discussion provides a high-level overview of the types of issues that boards of directors of both public and private companies may find relevant to focus on in the current environment.